However, reduced NME1 expression was found to have a significantly higher prevalence in squamous cell carcinoma (46%) than in adenocarcinoma (34%), and the difference was statistically significant (p = 0.01; Figure 1B). This evidence concerns the gene NME1 and adenocarcinoma.